Donghua Xu
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 23
- MicroRNA in disease regulation 18
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid 5
- Obstetrics and Gynecology top 5%
- Rheumatology top 5%
- Systemic Lupus Erythematosus Research 7
- Molecular Biology top 5%
- Extracellular vesicles in disease 13
- Circular RNAs in diseases 13
- Gut microbiota and health 6
- RNA modifications and cancer 4
- Journals
- SHILAP Revista de lepidopterología (1 paper)Bioresource Technology (1 paper)Inorganic Chemistry (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Donghua Xu
83 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 135
- Cancer Research 1.0k
- Nephrology 206
- Obstetrics and Gynecology 173
- Rheumatology 328
- Molecular Biology 1.5k
Countries citing papers authored by Donghua Xu
This map shows the geographic impact of Donghua Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donghua Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donghua Xu more than expected).
Fields of papers citing papers by Donghua Xu
This network shows the impact of papers produced by Donghua Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donghua Xu. The network helps show where Donghua Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Donghua Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 7 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 0 | |
| 10 | 2024 | 6 | |
| 11 | 2023 | 18 | |
| 12 | Peripheral Blood Leukocyte N6-methyladenosine is a Noninvasive Biomarker for Non-small-cell Lung Carcinoma | 2020 | 2 |
| 13 | 2020 | 131 | |
| 14 | 2019 | 88 | |
| 15 | 2018 | 48 | |
| 16 | 2015 | 69 | |
| 17 | 2015 | 44 | |
| 18 | 2014 | 33 | |
| 19 | 2013 | 10 | |
| 20 | Chemical and Physical Characteristics of Qinghai Oil Sand Ore | 2002 | 1 |
About Donghua Xu
Donghua Xu is a scholar working on Cancer Research, Rheumatology and Nephrology, having authored 90 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (23 papers), MicroRNA in disease regulation (18 papers), Extracellular vesicles in disease (13 papers), Circular RNAs in diseases (13 papers), Systemic Lupus Erythematosus Research (7 papers), Gut microbiota and health (6 papers), Gout, Hyperuricemia, Uric Acid (5 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (1.0k citations), Nephrology (206 citations) and Obstetrics and Gynecology (173 citations). Donghua Xu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Shushan Yan, Jing‐Hua Wang, Jinghan Yang, Hongying Lu, Min Cheng, Shushan Yan, Bin Wang, Beicheng Sun, Yangang Wang and Chengwen Jin. Their work appears in journals such as SHILAP Revista de lepidopterología, Bioresource Technology and Inorganic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.